# Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery

> **NCT04860115** · NA · UNKNOWN · sponsor: **St. Elizabeth Cancer Institute, Slovakia** · enrollment: 120 (estimated)

## Conditions studied

- Inflammatory Markers

## Interventions

- **PROCEDURE:** Modified pectoralis block (PEC II) and pecto-intercostal fascial plane block (PIFB)

## Key facts

- **NCT ID:** NCT04860115
- **Lead sponsor:** St. Elizabeth Cancer Institute, Slovakia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860115, "Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04860115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*